These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21308296)

  • 41. The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis.
    Ramey DR; Watson DJ; Yu C; Bolognese JA; Curtis SP; Reicin AS
    Curr Med Res Opin; 2005 May; 21(5):715-22. PubMed ID: 15974563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclooxygenase-2 inhibition by etoricoxib modulates plasma membrane fluidity in rat colon.
    Behal N; Kanwar SS; Kaur J; Sanyal SN
    J Environ Pathol Toxicol Oncol; 2008; 27(4):295-302. PubMed ID: 19105535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fixed drug eruption and generalised erythema following etoricoxib.
    Augustine M; Sharma P; Stephen J; Jayaseelan E
    Indian J Dermatol Venereol Leprol; 2006; 72(4):307-9. PubMed ID: 16880582
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-term tolerability of etoricoxib in different types of NSAID-intolerant subjects.
    Pagani M; Bonadonna P; Dama A; Senna GE; Vescovi PP; Antico A
    Eur Ann Allergy Clin Immunol; 2010 Dec; 42(6):216-20. PubMed ID: 21287945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiinflammatory effects of etoricoxib alone and combined with NSAIDs in LPS-induced reactive arthritis.
    Bressan E; Tonussi CR
    Inflamm Res; 2008 Dec; 57(12):586-92. PubMed ID: 19109739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L;
    Lancet; 2006 Nov; 368(9549):1771-81. PubMed ID: 17113426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing?
    Boursinos LA; Karachalios T; Poultsides L; Malizos KN
    J Musculoskelet Neuronal Interact; 2009; 9(1):44-52. PubMed ID: 19240368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
    Bickham K; Kivitz AJ; Mehta A; Frontera N; Shah S; Stryszak P; Popmihajlov Z; Peloso PM
    BMC Musculoskelet Disord; 2016 Aug; 17():331. PubMed ID: 27502582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of the newest COX-2 selective inhibitors in rheumatic disease.
    Baraf HS
    Curr Pharm Des; 2007; 13(22):2228-36. PubMed ID: 17691996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
    Brattwall M; Turan I; Jakobsson J
    Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study.
    Andersohn F; Schade R; Suissa S; Garbe E
    Stroke; 2006 Jul; 37(7):1725-30. PubMed ID: 16728684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tolerability to etoricoxib in patients with aspirin-exacerbated respiratory disease.
    Koschel D; Weber CN; Höffken G
    J Investig Allergol Clin Immunol; 2013; 23(4):275-80. PubMed ID: 23964558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of etoricoxib, a novel, selective COX-2 inhibitor.
    Dallob A; Hawkey CJ; Greenberg H; Wight N; De Schepper P; Waldman S; Wong P; DeTora L; Gertz B; Agrawal N; Wagner J; Gottesdiener K
    J Clin Pharmacol; 2003 Jun; 43(6):573-85. PubMed ID: 12817520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.
    Litalien C; Jacqz-Aigrain E
    Paediatr Drugs; 2001; 3(11):817-58. PubMed ID: 11735667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
    Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study.
    Kristensen LE; Jakobsen AK; Askling J; Nilsson F; Jacobsson LT
    Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1137-49. PubMed ID: 25623277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective and non-selective cyclooxygenase inhibitors delay stress fracture healing in the rat ulna.
    Kidd LJ; Cowling NR; Wu AC; Kelly WL; Forwood MR
    J Orthop Res; 2013 Feb; 31(2):235-42. PubMed ID: 22847634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats.
    Holzhausen M; Spolidorio DM; Muscará MN; Hebling J; Spolidorio LC
    J Periodontal Res; 2005 Jun; 40(3):208-11. PubMed ID: 15853965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs.
    Di Leo E; Aloia AM; Nettis E; Cardinale F; Foti C; Distaso M; Ferrannini A; Vacca A
    Int J Immunopathol Pharmacol; 2009; 22(4):1131-4. PubMed ID: 20074479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.